Sabril
Links shared publicly online about this topic
Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures
fda.gov — “Sabril (vigabatrin) oral solution has been approved by the u.s. food and drug administration to treat infantile spasms in children ages 1 month to 2 years. sabril is the first drug in the united states approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months. the disorder can be debilitating because of the frequency of difficult-to-control daily seizures.” View full resource at fda.gov
Most Recently Shared on August 21, 2009 at 6:04 pm By:
Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures http://bit.ly/2Hwoh
Sabril Approved By FDA To Treat Spasms In Infants And Epileptic Seizures
medicalnewstoday.com — “Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United S” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2009 at 2:47 pm By:
Sabril Approved By FDA To Treat Spasms In Infants And Epileptic Seizures: Sabril (vigabatrin) Oral Solution has .. http://bit.ly/3ySvRQ
Sabril available for infantile spasms and adult epileptic seizures - MPR
empr.com — “Lundbeck has made available Sabril (vigabatrin) powder for oral solution and tablets for the treatment of infantile spasms and refractory complex partial seizures.” View full resource at empr.com
Most Recently Shared on September 21, 2009 at 7:36 pm By:
MPR News: Sabril available for infantile spasms and adult epileptic seizures: Lundbeck has made availab.. http://bit.ly/XkmFg
Sabril approved for infantile spasms and adult epileptic seizures - MPR
empr.com — “The FDA has approved Sabril (vigabatrin, from Lundbeck) oral solution as monotherapy for infantile spasms in children 1 month to 2 years of age.” View full resource at empr.com
Most Recently Shared on August 24, 2009 at 3:22 pm By:
MPR News: Sabril approved for infantile spasms and adult epileptic seizures : The FDA has approved Sabr.. http://bit.ly/75nNv
Lundbeck Inc. Announces FDA Marketing Approval for Sabril for the Treatment of Two Difficult-to-Treat Epilepsies
drugs.com — “Sabril (vigabatrin) is used to treat infantile spasms and complex partial seizures. Includes Sabril side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 23, 2009 at 3:44 am By:
Lundbeck Inc. Announces FDA Marketing Approval for Sabril - http://bit.ly/JYKTQ
First Post-Baseline Data from the Sabril(R) (vigabatrin) Registry Presented at the American Epilepsy Society Annual Meeting - MarketWatch
marketwatch.com — “First Post-Baseline Data from the Sabril(R) (vigabatrin) Registry Presented at the American Epilepsy Society Annual Meeting - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on December 5, 2011 at 1:00 pm By:
Wils Eye's Robert Sergott, MD, presented post-baseline vision data on Sabril therapy at AES annual meeting, 12/4/11. http://t.co/I79onXAw
Weight Loss From Addiction Drug
webmd.com — “Vigabatrin, now being tested as a treatment for cocaine addiction, lessens obese rats' craving for food. They lose about 20% of their body weight.” View full resource at webmd.com
Most Recently Shared on August 20, 2008 at 4:30 pm By:
WebMD Health News Weight Loss From Addiction Drug: Vigabatrin, now being tested as a .. http://tinyurl.com/5mc6w9
Only Some Epilepsy Drugs Increase Risk of Suicide | Psych Central News
psychcentral.com — “A new study has determined that only some epilepsy drugs increase the risk for suicide. Currently, the Food and Drug Administration (FDA) requires a warning of” View full resource at psychcentral.com
Most Recently Shared on July 27, 2010 at 11:33 am By:
News: Only Some Epilepsy Drugs Increase Risk of Suicide http://bit.ly/b3wBIi
A Long And Deadly Wait - Forbes.com
forbes.com — “Sabril could help babies with brain-destroying seizures. So why did it take so long to approve?” View full resource at forbes.com
Most Recently Shared on September 30, 2009 at 12:37 pm By:
Why did a drug for kids with seizures take so long to approve? http://bit.ly/13SgXq
Medical News: FDA Approves First Infantile Spasm Treatment - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA approved the controversial antiseizure solution vigabatrin (Sabril) for spasms in children ages 1 month to 2 years.” View full resource at medpagetoday.com
Most Recently Shared on August 24, 2009 at 10:42 pm By:
FDA Approves First Infantile Spasm Treatment http://ow.ly/15MguW
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
MNT Neurology News
The latest neurology / neuroscience news published daily. Articles from research centers, universities and prestigious journals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement

